Fungal Infections After Lung Transplantation

Research output: Contribution to journalArticle

9 Scopus citations


Infection remains a significant source of morbidity and mortality after lung transplant, including fungal infection. Various antifungal prophylaxis agents are administered for a variable duration after transplant with the goal of preventing invasive fungal infections. Alternatively, some programs target the use of antifungal agents only in those colonized with Aspergillus species. Despite prophylaxis or pre-emptive therapy, a significant number of invasive fungal infections occur after lung transplant. Risk factors for fungal infections include single lung transplant, pretransplant Aspergillus colonization, environmental risks, structural lung disease such as cystic fibrosis, augmented immunosuppression, sinus disease, and use of indwelling airway stents.

Original languageEnglish (US)
JournalClinics in Chest Medicine
StateAccepted/In press - 2017


  • Fungal infection
  • Fungal prophylaxis
  • Lung transplantation
  • Solid organ transplantation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Fungal Infections After Lung Transplantation'. Together they form a unique fingerprint.

  • Cite this